Showing results (21-30 of 31) with videos related to
Sort By:
Pageof 4
Plos One|May 3, 2019
Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cellsJuan A Santamaria-Barria, Shan Zeng, Jonathan B Greer, et al.Annals of Surgical Oncology|December 16, 2025
Assessing Clinical Factors and Communication Barriers Impacting Postoperative Regret in Patients with Pancreatic CancerJudy Li, Thomas M Li, Adam Geffner, et al.Annals of Surgical Oncology|April 19, 2022
Gallbladder Cancer: A Single-Institution 10-Year Experience-Analysis of Adenocarcinoma Subtypes and Tumors Arising from Intracholecystic Papillary NeoplasmsYael Berger, Brianne J Sullivan, Natasha L Leigh, et al.Plos One|May 10, 2017
Genome and transcriptome profiling of fibrolamellar hepatocellular carcinoma demonstrates p53 and IGF2BP1 dysregulationEric C Sorenson, Raya Khanin, Zubin M Bamboat, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2016
PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal TumorsAdrian M Seifert, Shan Zeng, Jennifer Q Zhang, et al.Cancer Research|April 4, 2015
Pharmacological Inhibition of KIT Activates MET Signaling in Gastrointestinal Stromal TumorsNoah A Cohen, Shan Zeng, Adrian M Seifert, et al.The Journal of Experimental Medicine|December 11, 2013
KIT oncogene inhibition drives intratumoral macrophage M2 polarizationMichael J Cavnar, Shan Zeng, Teresa S Kim, et al.Annals of Surgical Oncology|December 21, 2023
Preoperative Frailty and Malnutrition in Surgical Oncology Patients Predicts Higher Postoperative Adverse Events and Worse Survival: Results of a Blinded, Prospective TrialNazanin Khajoueinejad, Elad Sarfaty, Allen T Yu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumorTeresa S Kim, Michael J Cavnar, Noah A Cohen, et al.Journal of Surgical Oncology|October 31, 2021
Induction FOLFIRINOX for patients with locally unresectable pancreatic ductal adenocarcinomaCaitlin A McIntyre, Noah A Cohen, Debra A Goldman, et al.Pageof 4